If burning feet are stealing your sleep, or your feet are slowly going numb, you're not imagining it — and you don't have to simply live with it. These are early signs of nerve damage, and caught early, neuropathy is very manageable. Our FDA-cleared DPN Check® shows exactly where your nerves stand in minutes, so your care is guided by facts, not guesswork.
Diabetic peripheral neuropathy (DPN) develops silently. Up to 50% of patients remain asymptomatic until the condition reaches advanced stages — by which point damage is often permanent. Traditional monofilament testing catches only the most obvious cases.
Nerve conduction studies can detect up to 3× more asymptomatic neuropathy than monofilament testing. That's why every neuropathy assessment at Boston Diabetes begins with objective measurement, not guesswork.
An FDA-cleared, non-invasive test with ~90% sensitivity vs EMG, delivering objective results in 10–15 seconds — used widely in clinics and research settings worldwide.
Every program follows the same three-stage pathway — comprehensive assessment, personalized intervention, and continuous outcome measurement.
DPN Check® nerve conduction test, foot examination, risk stratification and review of your history and glucose control.
A tailored plan combining glycaemic optimisation, nerve-protective therapy, pain management and lifestyle support.
Repeat testing tracks whether nerve function stabilises or improves — so care is guided by results, not assumptions.
The sooner we look, the more comfort and sensation we can help you keep.